GB00BMDQ2T15 (XLON)
Roquefort Therapeutics plc Share
3,93 GBX
Current Prices from Roquefort Therapeutics plc
Exchange | Ticker | Currency | Last Trade | Price | Daily Change | Daily Change % |
---|---|---|---|---|---|---|
London |
ROQ.L
|
GBX
|
23.12.2024 11:18
|
3,93 GBX
| 3,95 GBX | -0,51 % |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
-0,51 % | -12,67 % | -8,39 % | 7,97 % | -10,68 % | -45,79 % | -41,78 % |
Company Profile for Roquefort Therapeutics plc Share
Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
Company Data for Roquefort Therapeutics plc Share
Name Roquefort Therapeutics plc
Company Roquefort Therapeutics plc
Website https://www.roquefortinvest.com
Primary Exchange
London
ISIN GB00BMDQ2T15
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Trevor Ajanthan Reginald
Country United Kingdom
Currency GBX
Employees 0,0 T
Address Eccleston Yards, SW1W 9NF London
IPO Date 2021-03-22
Ticker Symbols
Name | Symbol |
---|---|
London | ROQ.L |
More Shares
Investors who Roquefort Therapeutics plc hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.